USPTO Rules In Favor of Geron In Patent Interference Over Cloning
The decision upholds the patentability of all of Geron's claims and finds all of the Infigen claims to be unpatentable.
The interference was between a patent application licensed to Geron from the Roslin Institute and an Infigen patent application.
The decision by the Board of Patent Appeals and Interferences...
To view the full article, register now.